Genopets is projected to rise to $0.003294 by 2027, a +4% move from its current price of $0.00317. GENE is currently trading above its 50-day average (a bullish sign). Technical indicators currently lean sell. Market sentiment sits at 27/100 (Fear) on the Fear & Greed Index.
A data-driven summary — not financial advice. See the full breakdown below.
Live market data via CoinGecko & CoinMarketCap · updated 8/1/2026
| Period | Min | Prediction | Max | Change |
|---|---|---|---|---|
| Aug 2 | $0.003036 | $0.003169 | $0.003309 | -0.02% |
| Aug 3 | $0.002981 | $0.003169 | $0.003368 | -0.05% |
| Aug 4 | $0.00294 | $0.003168 | $0.003413 | -0.07% |
| Aug 5 | $0.002906 | $0.003167 | $0.003452 | -0.10% |
| Aug 6 | $0.002875 | $0.003166 | $0.003487 | -0.12% |
| Aug 7 | $0.002848 | $0.003166 | $0.003518 | -0.15% |
| Aug 8 | $0.002824 | $0.003165 | $0.003547 | -0.17% |
| Period | Min | Prediction | Max | Change |
|---|---|---|---|---|
| Week 1 | $0.002824 | $0.003165 | $0.003547 | -0.17% |
| Week 2 | $0.002689 | $0.003159 | $0.003712 | -0.35% |
| Week 3 | $0.002589 | $0.003154 | $0.003842 | -0.52% |
| Week 4 | $0.002506 | $0.003148 | $0.003955 | -0.69% |
| Week 5 | $0.002436 | $0.003143 | $0.004056 | -0.86% |
| Week 6 | $0.002373 | $0.003137 | $0.004148 | -1.03% |
| Week 7 | $0.002316 | $0.003132 | $0.004235 | -1.20% |
Short-term targets derived from the forecast trend and recent volatility. Highly uncertain — not financial advice.
Genopets is a Free-to-Play, Move-to-Earn NFT game on Solana that makes it fun and profitable to live an active lifestyle.
Genopets combines user's step data from their mobile device and wearables with blockchain Play-to-Earn economics so players can earn crypto for taking action in real life as they explore the Genoverse evolving and battling their Genopet.
Genopets (GENE) is currently priced at $0.002595. Its market capitalization stands at $245.55K, and it is ranked 4357. All-time high is $37.83 and all-time low is $0.001069. The year-by-year forecast suggests a neutral stance in 2026 with an average price of $0.002595, followed by bullish momentum in later years.
The forecasted averages include 2027 $0.003473, 2028 $0.005534, 2029 $0.005021, 2030 $0.003382, 2031 $0.004234, 2032 $0.008715, 2033 $0.007198, 2035 $0.009038, 2040 $0.015, and 2050 $0.0101.
A major floor 46.8% below — a decisive break under it would weaken the trend.
The nearest floor, 16.9% below — buyers have tended to step in here.
The nearest ceiling, 13.1% above — a clean break opens room to run.
A major ceiling 28.9% above — clearing it would confirm fresh momentum.
Key GENE support and resistance from recent price action — levels where the trend has historically paused or reversed. Percentages are the distance from the current price.
A snapshot of GENE market posture derived from its technical indicators and recent volatility. Higher trend and alignment lean bullish; higher risk means larger swings.
Technical Analysis
Indicators computed on daily closing prices.
| Period | SMA | Action | EMA | Action |
|---|---|---|---|---|
| MA 5 | $0.003193 | Sell | $0.003214 | Sell |
| MA 10 | $0.003321 | Sell | $0.003276 | Sell |
| MA 20 | $0.003364 | Sell | $0.003281 | Sell |
| MA 50 | $0.003145 | Buy | $0.003133 | Buy |
| MA 100 | $0.00297 | Buy | $0.003012 | Buy |
| MA 200 | $0.002428 | Buy | $0.004902 | Sell |
| Name | Value | Action |
|---|---|---|
| RSI (14) | 46.58 | Neutral |
| Stoch RSI (14) | 11.63 | Buy |
| CCI (20) | -120.63 | Sell |
| Williams %R (14) | -87.04 | Info |
| MACD (12,26,9) | -0.00 | Sell |
| ROC (12) | -7.51 | Sell |
| Bollinger %B (20,2) | 0.16 | Neutral |
| Stochastic %K (14) | 12.96 | Buy |
| TRIX (15) | 0.43 | Buy |
| Awesome (5,34) | 0.00 | Buy |
| Ultimate (7,14,28) | 39.20 | Neutral |
| Momentum (10) | -0.00 | Sell |
| Aroon Osc (25) | 56.00 | Buy |
| Hull MA (9) | 0.00 | Buy |
| ADX (14) | 20.08 | Sell |
| ATR (14) | 0.00 | Info |
Sentiment: NEUTRAL. RSI14 is 40, indicating a neutral stance near the midpoint. The 50-day simple moving average is $0.002727 and the 200-day simple moving average is $0.002552.
Support sits at $0.00183 and resistance at $0.003517. The 30-day range runs from $0.001902 to $0.003542, reflecting a relatively tight move band around the current price.
| Year | Min | Avg | Max | ROI | Sentiment |
|---|---|---|---|---|---|
| $0.001408 | $0.00317 | $0.00317 | 0% | Neutral | |
| $0.002488 | $0.003294 | $0.004685 | +4% | Neutral | |
| $0.003719 | $0.005165 | $0.007761 | +63% | Bullish | |
| $0.00337 | $0.00487 | $0.007633 | +54% | Bullish | |
| $0.002737 | $0.004101 | $0.006655 | +29% | Bullish | |
| $0.001663 | $0.002575 | $0.004307 | -19% | Bearish | |
| $0.004569 | $0.007301 | $0.0125 | +130% | Bullish | |
| $0.004276 | $0.007038 | $0.0124 | +122% | Bullish | |
| $0.001755 | $0.002972 | $0.005347 | -6% | Neutral | |
| $0.002914 | $0.005074 | $0.009316 | +60% | Bullish | |
| $0.005528 | $0.011 | $0.0219 | +246% | Bullish | |
| $0.002927 | $0.006504 | $0.0146 | +105% | Bullish |
Current year — the forecast is anchored to the live price, so ROI shows 0%.
| Month | Min | Avg | Max | Change |
|---|---|---|---|---|
| August 2026 | $0.001408 | $0.00317 | $0.003534 | +0.00% |
| September 2026 | $0.002686 | $0.003234 | $0.004042 | +2.01% |
| October 2026 | $0.002547 | $0.0031 | $0.003938 | -4.15% |
| November 2026 | $0.001894 | $0.002326 | $0.002994 | -24.96% |
| December 2026 | $0.001673 | $0.002071 | $0.002697 | -10.97% |
Click any year to see its month-by-month GENE forecast. Min / Avg / Max are a bear / base / bull scenario; ROI is the projected move from the current price. Change is the month-over-month move in the average. Estimates, not guarantees.
Expect GENE to range from $0.001408 to $0.00317 through 2026. The $0.00317 average target implies a 0% move from current prices. Price action looks broadly range-bound.
The GENE price prediction for 2027 points to an average of $0.003294 (low $0.002488, high $0.004685) — a potential gain of +4% on today's $0.00317. A consolidation phase looks the most probable path here.
In 2028, GENE is projected to trade between $0.003719 and $0.007761, averaging $0.005165 — a potential gain of +63% from today's $0.00317. That is up +57% on the projected 2027 average. Momentum favours further upside here.
Genopets's 2029 outlook centres on $0.00487, within a $0.00337 to $0.007633 range. That is -6% versus the projected 2028 average. That marks a +54% change versus current levels. Buyers look set to stay in control over this stretch.
By 2030, GENE could reach as high as $0.006655, with a base case around $0.004101 and support toward $0.002737 — roughly +29% from $0.00317. Momentum favours further upside here.
Expect GENE to range from $0.001663 to $0.004307 through 2031. The $0.002575 average target implies a -19% move from current prices. That is -37% versus the projected 2030 average. Expect choppier, lower action through this leg of the cycle.
The GENE price prediction for 2032 points to an average of $0.007301 (low $0.004569, high $0.0125) — a potential gain of +130% on today's $0.00317. Momentum favours further upside here.
In 2033, GENE is projected to trade between $0.004276 and $0.0124, averaging $0.007038 — a potential gain of +122% from today's $0.00317. That is -4% versus the projected 2032 average. Buyers look set to stay in control over this stretch.
Genopets's 2034 outlook centres on $0.002972, within a $0.001755 to $0.005347 range. That is -58% versus the projected 2033 average. That marks a -6% change versus current levels. Price action looks broadly range-bound.
By 2035, GENE could reach as high as $0.009316, with a base case around $0.005074 and support toward $0.002914 — roughly +60% from $0.00317. Buyers look set to stay in control over this stretch.
Expect GENE to range from $0.005528 to $0.0219 through 2040. The $0.011 average target implies a +246% move from current prices. That is up +116% on the projected 2035 average. Momentum favours further upside here.
The GENE price prediction for 2050 points to an average of $0.006504 (low $0.002927, high $0.0146) — a potential gain of +105% on today's $0.00317. Buyers look set to stay in control over this stretch.
Investing $1,000 in GENE today (≈ 315,436.516824 GENE) could be worth
$2,051.51
+$1,051.51 (+105%) by 2050 · US Dollar
Based on the average projected GENE price of $0.01 in 2050.
Based on the base (average) forecast scenario. FX rates are indicative. Estimates only — not financial advice.
See what a past investment in GENEwould be worth at today's price.
$1,000 invested in GENE on Aug 1, 2025 (≈ 21,478.185999 GENE) would be worth
$68.09
-$931.91 (-93.2%) today · 0.07× · US Dollar
Based on a GENE entry price of $0.046559 vs. today's $0.00317.
| Invested | Entry price | Value today | Return |
|---|---|---|---|
| 1 week ago | $0.003394 | $934.05 | -6.6% |
| 1 month ago | $0.002565 | $1,236.02 | +23.6% |
| 3 months ago | $0.003865 | $820.17 | -18.0% |
| 6 months ago | $0.001652 | $1,918.56 | +91.9% |
| 1 year ago | $0.046559 | $68.09 | -93.2% |
| All time (1.2y) ago | $0.069778 | $45.43 | -95.5% |
Past performance from historical market data — it does not predict future results. FX rates are indicative. Not financial advice.
Enter a price to see how it sits against our GENE forecast.
Our base-case forecast reaches $0.0063 around 2032.
Implied market cap at $0.0063: $603.57K
The multi-year forecast shows bullish sentiment from 2027 onward, with the following highlights: 2027 avg $0.003473 and ROI 33.8%; 2028 avg $0.005534 and ROI 113.2%; 2029 avg $0.005021 and ROI 93.5%; 2030 avg $0.003382 and ROI 30.3% (all with a bullish sentiment). In 2040 the avg is $0.015 with ROI 477.2% and bullish sentiment, and in 2050 the avg is $0.0101 with ROI 290.9% and bullish sentiment.
The forecast also shows notable yearly activity such as 2032 avg $0.008715 with ROI 235.8% and 2033 avg $0.007198 with ROI 177.3%, and 2035 avg $0.009038 with ROI 248.2%. The forecast is subject to uncertainty and assumes these price paths as estimates, not guarantees. The asset exhibits high historical volatility, with annualized volatility 100%.
Tap a question to reveal the answer.
Avg $0.003382; min $0.002086; max $0.005881; ROI 30.3%; sentiment BULLISH.
The forecast shows bullish sentiment from 2027 onward, with multiple years of positive ROI (e.g., 33.8% in 2027, 113.2% in 2028, 93.5% in 2029, 30.3% in 2030, 63.1% in 2031, 235.8% in 2032, 177.3% in 2033, 248.2% in 2035, 477.2% in 2040, and 290.9% in 2050). However, these are estimates, not guarantees, and carry risk.
Yes. The forecast shows higher potential, with a 2040 max of $0.0329 and a 2050 max of $0.0233, while the 2035 and 2040 averages also exceed $0.01.
Current price is $0.002595 and market cap is $245.55K.
All-time high is $37.83 and all-time low is $0.001069.
Genopets Community Discussion
0Share your Genopets price prediction and read what the community thinks. Be respectful — comments are public and not financial advice.
Be the first to share your prediction…
What's your take? Add a comment above to start the conversation.